Delivery Order SPE2DB25D3306-SPE2DB25FUBGU
Award Date 4/8/25
Potential Completion Date 4/29/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,156.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 mg ORGOVYX tablets, a medication used to treat advanced prostate cancer. The delivery order has a completion date of June 16, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This delivery order, valued at $8,313.12, was awarded on August 28, 2025, to AmerisourceBergen Drug Corp for the supply of ORGOVYX (relugolix) 120 mg tablets in quantities of 30 units. The award was made without a set-aside designation through competitive procurement and is expected to be completed by September 19, 2025. The contract utilizes firm fixed pricing and is being funded by the Defense Logistics Agency's Medical Supply Chain division to support federal medical procurement needs. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of ORGOVYX (relugolix) 120 mg tablets in a quantity of 30 units under a firm fixed-price contract. The award, issued on August 8, 2025, carries a ceiling value of $1,385.52 and requires ultimate completion by August 29, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract will...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET, a medication used to treat prostate cancer. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of May 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of advanced prostate cancer,...
- The Defense Logistics Agency has awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30. The contract, designated as non-competitive with a firm fixed price structure, is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting DLA's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on June 25, 2025, with completion scheduled for July 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of October 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,855.20 firm fixed-price contract is for the delivery of ORGOVYX 120 MG TABLET prescription medication. The contract has an ultimate completion date of July 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...